Clinical Trial Update: Adherence With Iron Sprinkles Among High-Risk Infants [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating adherence to iron sprinkles in high-risk infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Iron Deficiency

Drugs mentioned

• Iron Sprinkles (ferrous iron supplement)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Anemia, Iron Deficiency | Phase 3 | Status: COMPLETED